GT Biopharma's total assets for Q1 2025 were $2.66M, a decrease of -37.19% from the previous quarter. GTBP total liabilities were $0.00 for the fiscal quarter, a -100.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.